FILTER
LATEST INTERVIEWS
Daniel J. O’Connor
PRESIDENT & CEO, ONCOSEC MEDICAL INCORPORATED
OnoSec Medical explains how treating cancers with a plasmid-based approach can avoid side effects and work on immunologically cold tumors.
Jorge Nogueira
CEO, DIPHARMA FRANCIS
Dipharma speaks to GBR of how it is adapting to market trends and expanding its geography.
Kenneth Lim
GENERAL MANAGER AND SITE DIRECTOR, NESTE SINGAPORE
Neste explains how it is expanding its renewable solutions’ production capacity in Singapore and its innovations in recycling waste.
Steve Botts
PRESIDENT, SANTA BARBARA CONSULTANTS
With growing concern over environmental, health and safety issues, Santa Barbara explains how it can assist miners in Peru.
Peter Meath
CO-HEAD OF HEALTHCARE AND LIFE SCIENCES, MIDDLE MARKET, J.P. MORGAN COMMERCIAL BANKING
"While the underlying business model for life sciences companies hasn’t changed as a result of our current environment, we’re seeing that increased capital has been made available to those seeking funding. This makes it an incredibly promising time for the sector."
Timothy J. Miller
PRESIDENT & CEO, FORGE BIOLOGICS
"What we are seeing is a reflection of the power of genetic medicine, where the technology has demonstrated clinical promise, as well as safety. Now, in many aspects, it is up to the manufacturing to catch up as that demand for gene therapy manufacturers far exceeds the capacity."
Lesley Millar-Nicholson
DIRECTOR, MIT TECHNOLOGY LICENSING OFFICE
"MIT spins out over 32 startup companies per year approximately, and we have about 358 companies that are still alive, so the ecosystem is functioning well."
Tom Butler
FORMER CEO, INTERNATIONAL COUNCIL ON MINING AND METALS (ICMM)
"The writing is on the wall for anyone who thinks that they can get by without paying proper attention to the Global Industry Standard on Tailings."
Adam Matthews
INVESTMENT TEAM DIRECTOR, CHURCH OF ENGLAND PENSIONS BOARD, & CO-CHAIR OF THE INVESTOR MINING & TAILINGS SAFETY INITIATIVE
"The collective realization that waste has been managed as an externality was alarming, and despite the good practice that existed within some companies, this was a sector-wide systemic challenge that needs serious focus from investors."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
